Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial
- Author
- Martine Bagot, Marie Maerevoet, Pier Luigi Zinzani, Fritz Offner (UGent) , Franck Morschhauser, Jean-Marie Michot, Vincent Ribrag, Maxime Battistella, Helene Moins, Angelica Calleri, Stephane Dalle, Marie Beylot-Barry, Karen Zwaenepoel, Koen De Winnie, Anne Marie-Cardine, Jean-Michel Cayuela, Valentina Tabanelli, Giovanna Motta, Federica Melle, Anna Hultberg, Domenica Gandini, Teresa Marafioti, Mahan Moshir, Tim Delahaye, Piotr Zabrocki, Karen Silence, Luc Van Rompaey, Armand Bensussan, Hans De Haard, Patrick Pauwels, Nicolas Leupin and Stefano A Pileri
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8618782
- MLA
- Bagot, Martine, et al. “Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial.” BLOOD, vol. 132, no. suppl. 1, 2018, doi:10.1182/blood-2018-99-118204.
- APA
- Bagot, M., Maerevoet, M., Zinzani, P. L., Offner, F., Morschhauser, F., Michot, J.-M., … Pileri, S. A. (2018). Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial. BLOOD, 132(suppl. 1). https://doi.org/10.1182/blood-2018-99-118204
- Chicago author-date
- Bagot, Martine, Marie Maerevoet, Pier Luigi Zinzani, Fritz Offner, Franck Morschhauser, Jean-Marie Michot, Vincent Ribrag, et al. 2018. “Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial.” In BLOOD. Vol. 132. https://doi.org/10.1182/blood-2018-99-118204.
- Chicago author-date (all authors)
- Bagot, Martine, Marie Maerevoet, Pier Luigi Zinzani, Fritz Offner, Franck Morschhauser, Jean-Marie Michot, Vincent Ribrag, Maxime Battistella, Helene Moins, Angelica Calleri, Stephane Dalle, Marie Beylot-Barry, Karen Zwaenepoel, Koen De Winnie, Anne Marie-Cardine, Jean-Michel Cayuela, Valentina Tabanelli, Giovanna Motta, Federica Melle, Anna Hultberg, Domenica Gandini, Teresa Marafioti, Mahan Moshir, Tim Delahaye, Piotr Zabrocki, Karen Silence, Luc Van Rompaey, Armand Bensussan, Hans De Haard, Patrick Pauwels, Nicolas Leupin, and Stefano A Pileri. 2018. “Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial.” In BLOOD. Vol. 132. doi:10.1182/blood-2018-99-118204.
- Vancouver
- 1.Bagot M, Maerevoet M, Zinzani PL, Offner F, Morschhauser F, Michot J-M, et al. Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial. In: BLOOD. 2018.
- IEEE
- [1]M. Bagot et al., “Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial,” in BLOOD, San Diego, CA, USA, 2018, vol. 132, no. suppl. 1.
@inproceedings{8618782, articleno = {{abstract 1627}}, author = {{Bagot, Martine and Maerevoet, Marie and Zinzani, Pier Luigi and Offner, Fritz and Morschhauser, Franck and Michot, Jean-Marie and Ribrag, Vincent and Battistella, Maxime and Moins, Helene and Calleri, Angelica and Dalle, Stephane and Beylot-Barry, Marie and Zwaenepoel, Karen and De Winnie, Koen and Marie-Cardine, Anne and Cayuela, Jean-Michel and Tabanelli, Valentina and Motta, Giovanna and Melle, Federica and Hultberg, Anna and Gandini, Domenica and Marafioti, Teresa and Moshir, Mahan and Delahaye, Tim and Zabrocki, Piotr and Silence, Karen and Van Rompaey, Luc and Bensussan, Armand and De Haard, Hans and Pauwels, Patrick and Leupin, Nicolas and Pileri, Stefano A}}, booktitle = {{BLOOD}}, issn = {{0006-4971}}, language = {{eng}}, location = {{San Diego, CA, USA}}, number = {{suppl. 1}}, title = {{Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial}}, url = {{http://doi.org/10.1182/blood-2018-99-118204}}, volume = {{132}}, year = {{2018}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: